News

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology\'s In the Lab eNewsletter-07-03-2018
Volume13
Issue 7

Micromeritics Acquires Freeman Technology

The acquisition expands Micromeritics’ portfolio of products and solutions.

Micromeritics Instrument Corporation, a manufacturer of premium products for advanced material characterization, announced on June 18, 2018, the acquisition of Freeman Technology. Located in Tewkesbury, United Kingdom, Freeman Technology provides instruments for measuring powder flow properties and other behavioral properties of powders. The instruments deliver data to assist in process and product understanding, accelerating formulation development and commercialization as well as supporting the optimization of powder processes.

“We are excited to welcome Freeman Technology to the Micromeritics family”, Preston Hendrix, president of Micromeritics, said in a press statement, noting that the acquisition expands Micromeritics’ portfolio of products and solutions. 

Managing director of Freeman Technology, Tim Freeman, added, “We are excited about becoming a Micromeritics company, as they have penetration in complementary segments, global market coverage and the infrastructure to help us accelerate the growth we have established in our business since 2000.”

Source:Freeman Technology

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content